S&P 500   3,231.86 (-3.17%)
DOW   28,039.88 (-3.29%)
QQQ   221.88 (-3.64%)
AAPL   300.43 (-4.03%)
MSFT   171.94 (-3.72%)
GOOGL   1,420.18 (-4.27%)
AMZN   2,005.15 (-4.33%)
NVDA   273.87 (-6.87%)
BABA   204.40 (-3.85%)
MU   54.68 (-4.05%)
GE   11.89 (-2.94%)
TSLA   835.90 (-7.23%)
AMD   49.06 (-7.92%)
T   38.37 (-0.47%)
ACB   1.55 (-7.19%)
F   7.64 (-3.17%)
NFLX   368.22 (-3.12%)
BAC   32.65 (-4.98%)
GILD   72.21 (+3.60%)
S&P 500   3,231.86 (-3.17%)
DOW   28,039.88 (-3.29%)
QQQ   221.88 (-3.64%)
AAPL   300.43 (-4.03%)
MSFT   171.94 (-3.72%)
GOOGL   1,420.18 (-4.27%)
AMZN   2,005.15 (-4.33%)
NVDA   273.87 (-6.87%)
BABA   204.40 (-3.85%)
MU   54.68 (-4.05%)
GE   11.89 (-2.94%)
TSLA   835.90 (-7.23%)
AMD   49.06 (-7.92%)
T   38.37 (-0.47%)
ACB   1.55 (-7.19%)
F   7.64 (-3.17%)
NFLX   368.22 (-3.12%)
BAC   32.65 (-4.98%)
GILD   72.21 (+3.60%)
S&P 500   3,231.86 (-3.17%)
DOW   28,039.88 (-3.29%)
QQQ   221.88 (-3.64%)
AAPL   300.43 (-4.03%)
MSFT   171.94 (-3.72%)
GOOGL   1,420.18 (-4.27%)
AMZN   2,005.15 (-4.33%)
NVDA   273.87 (-6.87%)
BABA   204.40 (-3.85%)
MU   54.68 (-4.05%)
GE   11.89 (-2.94%)
TSLA   835.90 (-7.23%)
AMD   49.06 (-7.92%)
T   38.37 (-0.47%)
ACB   1.55 (-7.19%)
F   7.64 (-3.17%)
NFLX   368.22 (-3.12%)
BAC   32.65 (-4.98%)
GILD   72.21 (+3.60%)
S&P 500   3,231.86 (-3.17%)
DOW   28,039.88 (-3.29%)
QQQ   221.88 (-3.64%)
AAPL   300.43 (-4.03%)
MSFT   171.94 (-3.72%)
GOOGL   1,420.18 (-4.27%)
AMZN   2,005.15 (-4.33%)
NVDA   273.87 (-6.87%)
BABA   204.40 (-3.85%)
MU   54.68 (-4.05%)
GE   11.89 (-2.94%)
TSLA   835.90 (-7.23%)
AMD   49.06 (-7.92%)
T   38.37 (-0.47%)
ACB   1.55 (-7.19%)
F   7.64 (-3.17%)
NFLX   368.22 (-3.12%)
BAC   32.65 (-4.98%)
GILD   72.21 (+3.60%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 ICU MedicalNuVasiveTandem Diabetes CareNevroIntegra Lifesciences
SymbolNASDAQ:ICUINASDAQ:NUVANASDAQ:TNDMNYSE:NVRONASDAQ:IART
Price Information
Current Price$207.50$73.09$86.35$135.18$58.28
52 Week RangeBuyBuyBuyBuyHold
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyHold
Consensus Price Target$203.00$79.67$79.79$103.83$63.78
% Upside from Price Target-2.17% downside9.00% upside-7.60% downside-23.19% downside9.43% upside
Trade Information
Market Cap$4.46 billion$3.92 billion$5.20 billion$4.16 billion$5.09 billion
Beta0.931.20.080.461.14
Average Volume113,748528,1791,708,947337,775581,201
Sales & Book Value
Annual Revenue$1.40 billion$1.17 billion$183.87 million$387.29 million$1.52 billion
Price / Sales3.063.2627.7510.823.30
Cashflow$11.36 per share$5.35 per shareN/AN/A$3.03 per share
Price / Cash18.2713.65N/AN/A19.25
Book Value$61.67 per share$17.58 per share$2.29 per share$8.14 per share$16.15 per share
Price / Book3.364.1637.7116.613.61
Profitability
Net Income$28.79 million$65.23 million$-122,610,000.00$-49,210,000.00$50.20 million
EPS$7.71$2.47($2.55)($1.64)$2.74
Trailing P/E Ratio61.3959.42N/AN/A100.48
Forward P/E Ratio33.7925.122,158.75N/A17.24
P/E GrowthN/A$2.23N/AN/A$1.65
Net Margins5.66%5.58%-7.19%-25.94%3.31%
Return on Equity (ROE)12.13%14.86%-9.44%-46.35%16.94%
Return on Assets (ROA)9.77%7.13%-5.50%-21.92%7.23%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.76%0.09%0.91%1.07%
Current Ratio3.70%3.69%2.46%5.87%2.92%
Quick Ratio2.35%2.18%2.05%4.54%1.92%
Ownership Information
Institutional Ownership Percentage94.02%99.99%91.09%N/A69.47%
Insider Ownership Percentage11.40%0.97%6.90%7.60%4.50%
Miscellaneous
Employees8,1002,6006538044,500
Shares Outstanding20.67 million52.15 million59.09 million31.01 million85.87 million
Next Earnings Date2/27/2020 (Confirmed)5/6/2020 (Estimated)2/24/2020 (Confirmed)2/25/2020 (Confirmed)4/22/2020 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel